- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
SST Group Presents Radiation Dosage Monitor
CHICAGO-SST Group will be demonstrating at RSNA 2015 for the first time its Radiation Dosage Monitor.
SST Group, a name known in the DICOM distribution realm, will debut at RSNA 2015 its Radiation Dosage Monitor (RDM).
RDM collects, controls, analyzes, and optimizes radiation dosages delivered to patients during medical imaging and interventional examinations, the company announced in a release. A Dose Archive and Communication (DACS) stores and manages radiation dose data for patient current and historical procedures and captures all diagnostic, interventional, and image-guided survival ionizing events, the release said.
The company claims RDM differs from the pack in that it acquires, stores, and analyzes data directly from the modality, which presents a more accurate dose estimate.
SST Group said that with all of the dose guidelines, the concept of DACS for radiation dosage management will eventually become what PACS is for DICOM images, and that patient dosage monitoring should provide a complete history of your facility’s population for all relevant events.
“This allows your facility to truly see the entire picture on a patient’s dosage history based on anatomical region,” Richard Murphy, president, SST Group, Inc., said in the release.
RDM is compatible with imaging modalities from all manufacturers, the release said.
Visit SST Group at booth 3254.
[[{"type":"media","view_mode":"media_crop","fid":"43623","attributes":{"alt":"","class":"media-image","id":"media_crop_2521141916971","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"4795","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 133px; width: 300px;","title":"SST Group, DACS","typeof":"foaf:Image"}}]]
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the recent RSNA conference.
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.
